跳至主要内容
临床试验/CTRI/2022/01/039242
CTRI/2022/01/039242尚未招募未知

Retrospective and prospective observational study toevaluate the outcome of patients with metastatic hormone-positivebreast cancer treated with a combination of chemotherapy andendocrine therapyâ??

ot applicable0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
ot applicable

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All patients above 18 yrs who have ER and/or PR positive and HER2 negative metastatic breast cancer and who have received a combination of chemotherapy and endocrine therapy between January
  • 2016 and December 2020.

排除标准

  • Patients who have HER2 positive tumors.

研究者

发起方
ot applicable

相似试验